These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 25219808)

  • 1. The genetic signatures of pediatric high-grade glioma: no longer a one-act play.
    Diaz AK; Baker SJ
    Semin Radiat Oncol; 2014 Oct; 24(4):240-7. PubMed ID: 25219808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma.
    Ocasio JK; Budd KM; Roach JT; Andrews JM; Baker SJ
    Cancer Metastasis Rev; 2023 Jun; 42(2):367-388. PubMed ID: 37119408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities.
    Haase S; Nuñez FM; Gauss JC; Thompson S; Brumley E; Lowenstein P; Castro MG
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas.
    Paugh BS; Zhu X; Qu C; Endersby R; Diaz AK; Zhang J; Bax DA; Carvalho D; Reis RM; Onar-Thomas A; Broniscer A; Wetmore C; Zhang J; Jones C; Ellison DW; Baker SJ
    Cancer Res; 2013 Oct; 73(20):6219-29. PubMed ID: 23970477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma.
    Jones C; Baker SJ
    Nat Rev Cancer; 2014 Oct; 14(10):. PubMed ID: 25230881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
    Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
    Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the H3K27M mutation on survival in pediatric high-grade glioma: a systematic review and meta-analysis.
    Lu VM; Alvi MA; McDonald KL; Daniels DJ
    J Neurosurg Pediatr; 2019 Mar; 23(3):308-316. PubMed ID: 30544362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor location, but not H3.3K27M, significantly influences the blood-brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma.
    Subashi E; Cordero FJ; Halvorson KG; Qi Y; Nouls JC; Becher OJ; Johnson GA
    J Neurooncol; 2016 Jan; 126(2):243-51. PubMed ID: 26511492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma.
    Wu G; Diaz AK; Paugh BS; Rankin SL; Ju B; Li Y; Zhu X; Qu C; Chen X; Zhang J; Easton J; Edmonson M; Ma X; Lu C; Nagahawatte P; Hedlund E; Rusch M; Pounds S; Lin T; Onar-Thomas A; Huether R; Kriwacki R; Parker M; Gupta P; Becksfort J; Wei L; Mulder HL; Boggs K; Vadodaria B; Yergeau D; Russell JC; Ochoa K; Fulton RS; Fulton LL; Jones C; Boop FA; Broniscer A; Wetmore C; Gajjar A; Ding L; Mardis ER; Wilson RK; Taylor MR; Downing JR; Ellison DW; Zhang J; Baker SJ
    Nat Genet; 2014 May; 46(5):444-450. PubMed ID: 24705251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invited Review: Emerging functions of histone H3 mutations in paediatric diffuse high-grade gliomas.
    Kasper LH; Baker SJ
    Neuropathol Appl Neurobiol; 2020 Feb; 46(1):73-85. PubMed ID: 31859390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal Transduction in Diffuse Intrinsic Pontine Glioma.
    Duchatel RJ; Jackson ER; Alvaro F; Nixon B; Hondermarck H; Dun MD
    Proteomics; 2019 Nov; 19(21-22):e1800479. PubMed ID: 31328874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting Edge Therapeutic Insights Derived from Molecular Biology of Pediatric High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG).
    Bailey CP; Figueroa M; Mohiuddin S; Zaky W; Chandra J
    Bioengineering (Basel); 2018 Oct; 5(4):. PubMed ID: 30340362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Genetics and Targeted Therapies for Paediatric High-grade Glioma.
    Rallis KS; George AM; Wozniak AM; Bigogno CM; Chow B; Hanrahan JG; Sideris M
    Cancer Genomics Proteomics; 2022; 19(4):390-414. PubMed ID: 35732328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric high-grade glioma: aberrant epigenetics and kinase signaling define emerging therapeutic opportunities.
    Sun Y; Bailey CP; Sadighi Z; Zaky W; Chandra J
    J Neurooncol; 2020 Oct; 150(1):17-26. PubMed ID: 32504402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma.
    Bailey CP; Figueroa M; Gangadharan A; Yang Y; Romero MM; Kennis BA; Yadavilli S; Henry V; Collier T; Monje M; Lee DA; Wang L; Nazarian J; Gopalakrishnan V; Zaky W; Becher OJ; Chandra J
    Neuro Oncol; 2020 Sep; 22(9):1302-1314. PubMed ID: 32166329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic programming of pediatric high-grade glioma: Pushing beyond proof of concept to clinical benefit.
    Groves A; Cooney TM
    Front Cell Dev Biol; 2022; 10():1089898. PubMed ID: 36589742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.
    Barrow J; Adamowicz-Brice M; Cartmill M; MacArthur D; Lowe J; Robson K; Brundler MA; Walker DA; Coyle B; Grundy R
    Neuro Oncol; 2011 Feb; 13(2):212-22. PubMed ID: 21138945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenomic landscape and 3D genome structure in pediatric high-grade glioma.
    Wang J; Huang TY; Hou Y; Bartom E; Lu X; Shilatifard A; Yue F; Saratsis A
    Sci Adv; 2021 Jun; 7(23):. PubMed ID: 34078608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease.
    Paugh BS; Qu C; Jones C; Liu Z; Adamowicz-Brice M; Zhang J; Bax DA; Coyle B; Barrow J; Hargrave D; Lowe J; Gajjar A; Zhao W; Broniscer A; Ellison DW; Grundy RG; Baker SJ
    J Clin Oncol; 2010 Jun; 28(18):3061-8. PubMed ID: 20479398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.